This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (87)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • World Health  • Pulmonary Diseases, Other  • Tuberculosis/ Other Mycobacterium  • Alert me on articles by topic

Discrepancy Between the Tuberculin Skin Test and the Whole-Blood Interferon Assay for the Diagnosis of Latent Tuberculosis Infection in an Intermediate Tuberculosis-Burden Country

Young Ae Kang, MD; Hye Won Lee, MSc; Ho Il Yoon, MD; BeLong Cho, MD; Sung Koo Han, MD; Young-Soo Shim, MD; Jae-Joon Yim, MD

JAMA. 2005;293:2756-2761.

Context  A recently developed whole-blood interferon (IFN-) assay based on stimulation with the Mycobacterium tuberculosis–specific antigens early secreted antigenic target 6 and culture filtrate protein 10 shows promise for the diagnosis of latent tuberculosis (TB) infection.

Objective  To compare the tuberculin skin test (TST) and the whole-blood IFN- assay in the diagnosis of latent TB infection according to the intensity of exposure.

Design and Setting  A prospective comparison between the whole-blood IFN- assay and the TST using a 2-TU dose of purified protein derivative RT23 in a population with intermediate TB burden was conducted sequentially between February 1, 2004, and February 28, 2005, in a Korean tertiary referral hospital.

Participants  Of 273 participants, 220 (95.7%) had received BCG vaccine. Participants were grouped according to their risk of infection: group 1, no identifiable risk of M tuberculosis infection (n = 99); group 2, recent casual contacts (n = 72); group 3, recent close contacts (n = 48); group 4, bacteriologically or pathologically confirmed TB patients (n = 54).

Main Outcome Measures  Levels of agreement between the TST and the IFN- assay and the likelihood of infection in the various groups.

Results  For the TST with a 10-mm induration cutoff, the positive response rate in group 1 was 51%; group 2, 60%; group 3, 71%, and group 4, 78%. For the IFN- assay, the positive response rate in group 1 was 4%; group 2, 10%; group 3, 44%; and group 4, 81%. The overall agreement between the TST and the IFN- assay in healthy volunteers was = 0.16. The odds of a positive test result per unit increase in exposure across the 4 groups increased by a factor of 5.31 (95% confidence interval [CI], 3.62-7.79) for the IFN- assay and by a factor of 1.52 (95% CI, 1.20-1.91) for the TST (P<.001). Using a 15-mm induration cutoff for the TST did not make a substantial difference to the test results.

Conclusion  The IFN- assay is a better indicator of the risk of M tuberculosis infection than TST in a BCG-vaccinated population.

Author Affiliations: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute (Drs Kang, Yoon, Han, Shim, and Yim and Ms Lee) and Department of Family Medicine (Dr Cho), Seoul National University College of Medicine, Seoul, Republic of Korea.

RELATED ARTICLES

Mycobacterium tuberculosis Infection in Health Care Workers in Rural India: Comparison of a Whole-Blood Interferon Assay With Tuberculin Skin Testing
Madhukar Pai, Kaustubh Gokhale, Rajnish Joshi, Sandeep Dogra, Shriprakash Kalantri, Deepak K. Mendiratta, Pratibha Narang, Charles L. Daley, Reuben M. Granich, Gerald H. Mazurek, Arthur L. Reingold, Lee W. Riley, and John M. Colford, Jr
JAMA. 2005;293(22):2746-2755.
ABSTRACT | FULL TEXT  

Diagnosis of Latent Tuberculosis Infection: Measure for Measure
Christopher C. Whalen
JAMA. 2005;293(22):2785-2787.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Systematic Review: T-Cell-Based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update
Pai et al.
ANN INTERN MED 2008;0:0000605-200808050-00241-E-241.
ABSTRACT | FULL TEXT  

Comparison of Sensitivities of Two Commercial Gamma Interferon Release Assays for Pulmonary Tuberculosis
Chee et al.
J. Clin. Microbiol. 2008;46:1935-1940.
ABSTRACT | FULL TEXT  

The Effect of Previous Tuberculin Skin Test on the Follow-up Examination of Whole-Blood Interferon-{gamma} Assay in the Screening for Latent Tuberculosis Infection
Choi et al.
Chest 2008;133:1415-1420.
ABSTRACT | FULL TEXT  

Predictive Value of a Whole Blood IFN-{gamma} Assay for the Development of Active Tuberculosis Disease after Recent Infection with Mycobacterium tuberculosis
Diel et al.
Am. J. Respir. Crit. Care Med. 2008;177:1164-1170.
ABSTRACT | FULL TEXT  

Interferon-gamma assay in tuberculous uveitis
Brogden et al.
Br. J. Ophthalmol. 2008;92:582-583.
FULL TEXT  

Reproducibility of QuantiFERON-TB Gold In-Tube Assay
Perry et al.
CVI 2008;15:425-432.
ABSTRACT | FULL TEXT  

Comparison of T-Spot.TB and tuberculin skin test among silicotic patients
Leung et al.
Eur Respir J 2008;31:266-272.
ABSTRACT | FULL TEXT  

Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot
Jafari et al.
Eur Respir J 2008;31:261-265.
ABSTRACT | FULL TEXT  

Use of a T-cell interferon-{gamma} release assay for the diagnosis of tuberculous pleurisy
Losi et al.
Eur Respir J 2007;30:1173-1179.
ABSTRACT | FULL TEXT  

Diagnostic Usefulness of a T-cell Based Assay for Extrapulmonary Tuberculosis
Kim et al.
Arch Intern Med 2007;167:2255-2259.
ABSTRACT | FULL TEXT  

Clinical Utility of Interferon Gamma Assay in the Diagnosis of Tuberculosis
Madariaga et al.
J Am Board Fam Med 2007;20:540-547.
ABSTRACT | FULL TEXT  

Usefulness of Whole-Blood Interferon-{gamma} Assay and Interferon-{gamma} Enzyme-Linked Immunospot Assay in the Diagnosis of Active Pulmonary Tuberculosis
Kang et al.
Chest 2007;132:959-965.
ABSTRACT | FULL TEXT  

Discrepancy between Mycobacterium tuberculosis-Specific Gamma Interferon Release Assays Using Short and Prolonged In Vitro Incubation
Leyten et al.
CVI 2007;14:880-885.
ABSTRACT | FULL TEXT  

Diagnosing Tuberculosis Infection in the 21st Century: New Tools To Tackle an Old Enemy
Lalvani
Chest 2007;131:1898-1906.
ABSTRACT | FULL TEXT  

Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-{gamma} assay
Leyten et al.
Eur Respir J 2007;29:1212-1216.
ABSTRACT | FULL TEXT  

Comparison of Mantoux and QuantiFERON TB Gold Tests for Diagnosis of Latent Tuberculosis Infection in Army Personnel
Franken et al.
CVI 2007;14:477-480.
ABSTRACT | FULL TEXT  

Comparison of an Interferon-{gamma} Release Assay with Tuberculin Skin Testing in HIV-infected Individuals
Luetkemeyer et al.
Am. J. Respir. Crit. Care Med. 2007;175:737-742.
ABSTRACT | FULL TEXT  

Comparison of Two Interferon-{gamma} Assays and Tuberculin Skin Test for Tracing Tuberculosis Contacts
Arend et al.
Am. J. Respir. Crit. Care Med. 2007;175:618-627.
ABSTRACT | FULL TEXT  

Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research
Menzies et al.
ANN INTERN MED 2007;146:340-354.
ABSTRACT | FULL TEXT  

Effect of HIV-1 Infection on T-Cell-based and Skin Test Detection of Tuberculosis Infection
Rangaka et al.
Am. J. Respir. Crit. Care Med. 2007;175:514-520.
ABSTRACT | FULL TEXT  

Detecting Latent Tuberculosis Infection in Hemodialysis Patients: A Head-to-Head Comparison of the T-SPOT.TB Test, Tuberculin Skin Test, and an Expert Physician Panel
Passalent et al.
CJASN 2007;2:68-73.
ABSTRACT | FULL TEXT  

Cost-optimisation of screening for latent tuberculosis in close contacts
Sadatsafavi and Najafzadeh
Eur Respir J 2006;28:1285-1285.
FULL TEXT  

Rapid Diagnosis of Smear-negative Tuberculosis by Bronchoalveolar Lavage Enzyme-linked Immunospot
Jafari et al.
Am. J. Respir. Crit. Care Med. 2006;174:1048-1054.
ABSTRACT | FULL TEXT  

An Update on the Diagnosis of Tuberculosis Infection
Richeldi
Am. J. Respir. Crit. Care Med. 2006;174:736-742.
ABSTRACT | FULL TEXT  

Predicting Non-Completion of Treatment for Latent Tuberculous Infection: A Prospective Survey
Shieh et al.
Am. J. Respir. Crit. Care Med. 2006;174:717-721.
ABSTRACT | FULL TEXT  

Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis.
Tsiouris et al.
J. Clin. Microbiol. 2006;44:2844-2850.
ABSTRACT | FULL TEXT  

Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test
Diel et al.
Eur Respir J 2006;28:16-23.
ABSTRACT | FULL TEXT  

Assessing tuberculosis transmission and virulence: the vanishing tuberculin skin test.
Schluger
Am. J. Respir. Crit. Care Med. 2006;173:942-943.
FULL TEXT  

Transmission of Mycobacterium tuberculosis Undetected by Tuberculin Skin Testing
Anderson et al.
Am. J. Respir. Crit. Care Med. 2006;173:1038-1042.
ABSTRACT | FULL TEXT  

Update in tuberculosis 2005.
Yew and Leung
Am. J. Respir. Crit. Care Med. 2006;173:491-498.
FULL TEXT  

Comparison of a New ESAT-6/CFP-10 Peptide-Based Gamma Interferon Assay and a Tuberculin Skin Test for Tuberculosis Screening in a Moderate-Risk Population
Porsa et al.
CVI 2006;13:53-58.
ABSTRACT | FULL TEXT  

Diagnosis of Latent TB: Simple Skin Test or "High-Tech" Interferon Assay?
JWatch Infect. Diseases 2005;2005:8-8.
FULL TEXT  

Diagnosis of Latent Tuberculosis Infection: Measure for Measure
Whalen
JAMA 2005;293:2785-2787.
FULL TEXT  

Tuberculosis--A Global Problem Requiring a Global Solution
DeAngelis and Flanagin
JAMA 2005;293:2793-2794.
FULL TEXT